Search bioRxiv⌕ Search

Biology subjects

Kuwabara, H.

Publications and source records attributed to Kuwabara, H..

4 recordsLinked to original sources

Influence of Substrate Elastic Modulus on Cell Shape and Displacement During the Motility Cycle

Cardiac fibroblasts play a pivotal role in heart tissue dynamics, responding to mechanical cues from their environment. This study examines how substrate elasticity influences the motility and shape of chicken embryonic cardiac fibroblasts on polydimethylsiloxane (PDMS) substrates of different stiffness (10 kPa and 400 kPa). Using time-lapse phase-contrast microscopy, we identified distinct motility cycles characterized by elongation, contraction, and retraction phases. On soft substrates, cells exhibited slower retraction speeds and longer motility cycles compared to those on hard substrates. Notably, cells on soft substrates left trailing edges upon retraction, leading to pronounced morphological oscillations, whereas cells on hard substrates adopted near-circular shapes with less coordinated motility. Quantitative analyses revealed that the duration of the static phase was significantly shorter on hard substrates, correlating with differences in cell shape parameters, including length, circularity, and area. These findings suggest that substrate elasticity modulates the balance between cell-substrate adhesion and contractile forces, influencing cell polarity and motility. Our work advances the understanding of how mechanical environments shape fibroblast dynamics, offering insights relevant to tissue engineering and fibrosis research. SIGNIFICANCEMechanical cues from the cellular microenvironment are known to regulate cell behavior, yet how substrate stiffness shapes the dynamic motility cycle of fibroblasts remains incompletely understood. Here, we use high-resolution time-lapse imaging to reveal that cardiac fibroblasts on soft (10 kPa) PDMS undergo polarized, oscillatory migration with prolonged static phases, while those on stiff (400 kPa) substrates exhibit rapid retraction and random-like displacement with reduced polarity. These findings highlight how substrate elasticity modulates the interplay between traction forces and adhesion stability, governing directionality and morphology. This work provides mechanobiological insights into fibroblast behavior with implications for designing biomaterials to guide tissue remodeling and fibrosis progression.

biophysics↗

Two Stabiliser loci in Antirrhinum suppress the transposition of Tam3 without compromising transposase production

Antirrhinum majus has been known to exhibit occasional instabilities that are manifested as variegations and morphological chimeras. Stabiliser (St) is a historical locus that stabilizes phenotypically unstable or mutable traits in Antirrhinum. Here, we characterized two St loci, the previously described Old Stabiliser (OSt) and New Stabiliser (NSt), in Antirrhinum that specifically suppress the transposition of the Class II DNA transposable element, Tam3. Both St loci involve derivatives of Tam3 with unique structures: OSt has a pseudo-Tam3 copy whose 5-terminal region has been rearranged compared to the cognate Tam3 element, and NSt consists of two intact copies of Tam3 in a head-to-head orientation. Neither locus interferes with the production of the intact Tam3 transposase (TPase) or the nuclear import of TPase. Both OSt and NSt produce specific sRNAs from their 5 terminal regions containing multiple TPase binding motifs. These specific sRNAs could repress Tam3 transposition by interacting with the TPase binding motifs within the Tam3 element or with the TPase itself.

genetics↗

First in-human PET study of 3 novel tau radiopharmaceuticals: RO6958948

Background[11C]RO-963, [11C]RO-643 and [18F]RO-948 (previously referred as [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948, respectively) have been reported as promising PET tracers for tau imaging based on in vitro and preclinical PET data (1,2). Here we describe the first human evaluation of these novel radiotracers.\n\nMethodsAmyloid PET positive Alzheimers disease (AD) patients and young healthy subjects (YC) each received two different tau tracers. Dynamic 90 min scans were obtained after bolus injection of [11C]RO-963, [11C]RO-643 or [18F]RO-948. Arterial blood sampling was performed in 11 healthy controls (HC) and 11 AD. Regions were defined on MRI, and PET data were quantified by plasma reference graphical analysis (for VT) and target cerebellum ratio (SUVR60-90). SUVR images were also analyzed voxelwise. Five older healthy subjects (OC) each received two scans with [18F]RO-948 for evaluation of test-retest variability. Four AD subjects received a repeat [18F]RO-948 scan over about 1 year. Six additional HC (3M: 3F; 41-67y) each received one whole body dosimetry scan with [18F]RO-948.\n\nResultsIn YC, peak SUV values were observed in the temporal lobe with values of approximately 3.0 for [11C]RO-963, 1.5 for [11C]RO-643 and 3.5 for [18F]RO-948. Over all brain regions and subjects, the trend was that [18F]RO-948 had the highest peak SUV value, followed by [11C]RO-963, and then [11C]RO-643. Regional analysis of SUVR and VT for [11C]RO-643 and [18F]RO-948 clearly discriminated AD and HC groups. Compartmental modeling confirmed that [11C]RO-643 had lower brain entry than both [18F]RO-963 and [18F]RO-948, and [18F]RO-948 showed a better contrast between (predicted) areas of high vs low tau accumulation. Thus, our subsequent analysis focused on [18F]RO-948. Both voxelwise and region-based analysis of [18F]RO-948 binding in HC vs AD revealed multiple areas where AD and HC significantly differed. Of 22 high-binding regions, 13 showed significant group difference (following ANOVA, F=45, p<10-5). Voxelwise analysis also revealed a set of symmetrical clusters where AD>HC (threshold of p<0.001, cluster size k>50).\n\nConclusions[18F]RO-948 demonstrates superior characteristics to [11C]RO-643 and [18F]RO-963 for characterization of tau pathology in AD. Regional binding data and kinetic properties of RO-948 compare favorably with existing other tau PET tracers.

neuroscience↗

PET Brain imaging of α7-nAChR with ASEM Reproducibility, occupancy, receptor density, and changes in schizophrenia

The 7 nicotinic acetylcholine receptor (nAChR) increasingly has been implicated in normal brain physiology, as well as in neuropsychiatric disorders. The a7-nAChR primarily is located in cerebral cortex and sub-cortical regions, compared to the 4{beta}2 nAChR subtype that has a more subcortical distribution. The highly cortical distribution suggests a role of a7-nAChR in cognition. We expanded the first-in-human PET imaging of 7-nAChR with [18F]ASEM from five to 21 healthy non-smoking volunteers and added preliminary evidence of binding in six male patients with schizophrenia. Study aims included 1) confirmation of test-retest reproducibility of [18F]ASEM binding in normal volunteers, 2) demonstration of specificity of [18F]ASEM binding by competition with DMXB-A, an 7-nAChR partial agonist previously tested in clinical trials of patients with schizophrenia, 3) estimation of [18F]ASEM binding potentials and 7-nAChR density in vivo in humans, and 4) 7-nAChR binding in patients with schizophrenia compared to healthy volunteers.\n\nTest-retest PET confirmed reproducibility (>90%) (variability [&le;] 7%) of [18F]ASEM volume of distribution (VO_SCPLOWTC_SCPLOW) estimates in healthy volunteers. Repeated sessions of PET in five healthy subjects included baseline and effect of inhibition after oral administration of 150 mg DMXB-A. From reduction of binding potentials, we estimated the dose-dependent occupancy of 7-nAChR by DMXB-A at 17-49% for plasma concentrations at 60-200 nM DMXB-A. In agreement with evidence post-mortem, 7-nAChR density (Bmax) averaged 0.67-0.82 nM and inhibitor affinity constant (KO_SCPLOWIC_SCPLOW) averaged 170-385 nM. Median VO_SCPLOWTC_SCPLOW in a feasibility study of six patients with schizophrenia was lower than in healthy volunteers in cingulate cortex, frontal cortex, and hippocampus. Mann-Whitney test identified cingulate cortex and hippocampus as regions with significantly lower median VO_SCPLOWTC_SCPLOW in patients than in healthy volunteers when a single outlier patient was excluded from analysis (P = 0.02, corrected for multiple comparisons).

neuroscience↗